Summit Therapeutics
SMMT
#1639
Rank
$13.06 B
Marketcap
$16.33
Share price
15.08%
Change (1 day)
-10.77%
Change (1 year)

Summit Therapeutics (SMMT) - Net assets

Net assets on the balance sheet as of June 2026 : $0.62 Billion USD

According to Summit Therapeutics 's latest financial reports the company has $0.62 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Summit Therapeutics - Net assets on balance sheet (from 2020 to 2020)

Net assets by year

Year Net assets Change
2023-12-31$$77.69 M-38.66%
2022-12-31$$0.12 B52.07%
2021-12-31$$83.28 M4.82%
2020-12-31$$79.45 M
2019-01-31$$73.18 M-1258.7%
2018-01-31$-$6.32 Million15.72%
2017-01-31$-$5.46 Million-116.73%
2016-01-31$$32.62 M10.72%
2015-01-31$$29.46 M127.36%
2014-01-31$$12.95 M82.17%
2013-01-31$$7.11 M19.87%
2012-01-31$$5.93 M-35.58%
2011-01-31$$9.21 M-56.33%
2010-01-31$$21.09 M20.42%
2009-01-31$$17.51 M-83.73%
2008-01-31$$0.10 B36.69%
2007-01-31$$78.75 M89.43%
2006-01-31$$41.57 M-16.82%
2005-01-31$$49.98 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Sarepta Therapeutics
SRPT
$1.52 B 142.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
$0.22 B-64.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
$60.83 M-90.34%๐Ÿ‡บ๐Ÿ‡ธ USA